"Shenwan Hongyuan Group (06806): The "25 Shen D11" will be redeemed and delisted on January 23rd."

19:53 26/01/2026

Shenwan Hongyuan (06806) announced that its subsidiary, Shenwan Hongyuan Securities Co., Ltd., will issue short-term corporate bonds (Series 1) for professional investors on October 23, 2025. The bonds, with a total value of 1.3 billion yuan and a term of 92 days, will mature and be delisted on January 23, 2026. The bonds are referred to as "25 Shen D11" and have a coupon rate of 1.66%.

Shenwan Hongyuan Group (06806) announced that its subsidiary, Shenwan Hongyuan Group Securities Co., Ltd., will issue short-term corporate bonds (first tranche) targeted at professional investors on October 23, 2025. The bonds, with the name "25 ShenD11," will mature and be delisted on January 23, 2026, with a total issuance size of 1.3 billion RMB, a term of 92 days, and a coupon rate of 1.66%.

Xiamen Amoytop Biotech (688278.SH) plans to issue convertible bonds to raise no more than 1.533 billion yuan.

CHINARES PHARMA (03320) subsidiary China Resources Double-Crane Pharmaceutical has been approved to issue corporate bonds totaling 3 billion yuan.

Shanghai Anlogic Infotech (688107.SH) plans to raise up to 1.262 billion yuan through a private placement.

Xiamen Amoytop Biotech (688278.SH) plans to issue convertible bonds to raise no more than 1.533 billion yuan.

CHINARES PHARMA (03320) subsidiary China Resources Double-Crane Pharmaceutical has been approved to issue corporate bonds totaling 3 billion yuan.

Shanghai Anlogic Infotech (688107.SH) plans to raise up to 1.262 billion yuan through a private placement.